No Data
No Data
Special Treat Huamei (600360.SH): Some machinery and equipment are pledged for loans.
On December 12, Gelonghui reported that ST Jilin Sino-Microelectronics (600360.SH) announced that on December 12, 2024, the sixth meeting of the ninth Board of Directors reviewed and approved the proposal from Jilin Sino-Microelectronics Co., Ltd. regarding the mortgage loan of some machinery and equipment. The Board of Directors believes that this mortgage loan is a follow-up loan after the loan maturity, and agrees that the company will sign a "Machine Equipment Mortgage Contract" with the Jilin Branch of the Export-Import Bank of China for a total of 210,000,000.00 yuan. This asset mortgage meets the interests of the company and the Shareholder, and does not harm the company and the Shareholder, especially the minority Shareholders.
ST HuaWei: Jilin HuaWei Electronics Co., Ltd. 2024 Third Quarter Report
Jilin HuaWei Electronics Co., Ltd. Report for the Third Quarter of 2024
Express News | ST Huami: The net income in the first three quarters increased by 371.14% year-on-year.
Express News | This week, a total of 10 listed companies announced that the company or related parties were filed the next day after the announcement, Nuotai Biotechnology approached the 20% lower limit during the day.
October 28th A-share investment lightning rod︱ Huashuo High-Tech: Shareholder Guotou Chuangye Fund intends to shareholding no more than 2% of shares; Moko Shares: Terminates major assets restructuring.
Beijing Aerospace Shenzhou Intelligent Equipment Technology's controlling shareholder's concerted action intends to reduce their shareholding by no more than 1%; Huashuo Gaokex's shareholder Guotou Chuangye Fund intends to reduce their shareholding by no more than 2%; Xiangyu Medical's shareholders Suzhou Jifeng, Jiaxing Jifeng No. 1, Fuzhou Jifeng intend to collectively reduce their shareholding by no more than 1.99%; Ningbo Fangzheng was investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws and regulations; Hubei Guangji Pharmaceutical was investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws and regulations; Moko Group terminated a major asset restructuring; Special Treat Huawei's shareholder received a notice of investigation from the China Securities Regulatory Commission.